Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2 clinical trials
Epidemiological Study of Fabry Disease Screening in Chronic Kidney Disease Patients

glycosphingolipids, predominantly globotriaosylceramide (Gb3), within cell lysosomes throughout the body. In patients at the second or third decade, progressive proteinuria, decline in glomerular filtration

globotriaosylceramide
deficiency
deficit
gla gene
glycosphingolipids
  • 0 views
  • 29 Sep, 2021
  • 1 location
Inflammatory Pathways and Cardiac Growth Factors Associated With Fabry Disease Cardiomyopathy

In Fabry disease (FD), -galactosidase A deficiency leads to the accumulation of globotriaosylceramide (Lyso-Gb3 and Gb3), triggering a pathologic cascade that causes progressive damage to

  • 0 views
  • 05 Feb, 2021
  • 1 location